The historical rank and industry rank for Kim Forest Enterprise Co's FCF Margin % or its related term are showing as below:
TPE:6645'
s FCF Margin % Range Over the Past 10 Years
Min: -53.88 Med: -16.04 Max: 13.48
Current: -21.03
During the past 13 years, the highest FCF Margin % of Kim Forest Enterprise Co was 13.48%. The lowest was -53.88%. And the median was -16.04%.
TPE:6645's FCF Margin % is ranked worse than 65.69% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845
vs TPE:6645: -21.03
Kim Forest Enterprise Co FCF Margin % Related Terms
Kim Forest Enterprise Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6645 vs TMO, DHR, IDXX: FCF Margin % Comparison
For the Diagnostics & Research subindustry, Kim Forest Enterprise Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kim Forest Enterprise Co FCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Kim Forest Enterprise Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Kim Forest Enterprise Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kim Forest Enterprise Co (TPE:6645) has a FCF Margin % of 11.08% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kim Forest Enterprise Co and its competitors. According to the industry distribution chart, Kim Forest Enterprise Co ranks #134 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 65.7%.
Is Kim Forest Enterprise Co's FCF Margin % too high?
Kim Forest Enterprise Co's current FCF Margin % is 11.08%. Based on the distribution chart, Kim Forest Enterprise Co ranks #134 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Kim Forest Enterprise Co has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kim Forest Enterprise Co's FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Kim Forest Enterprise Co ranks #134 out of 204 companies for FCF Margin %. This places Kim Forest Enterprise Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kim Forest Enterprise Co and its competitors. Kim Forest Enterprise Co's current FCF Margin % is 11.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kim Forest Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Kim Forest Enterprise Co (TPE:6645) is currently considered Possible Value Trap. The stock's GF Value™ is NT$24.71, compared to a current price of NT$15.90 — trading 35.7% below its estimated fair value. The current FCF Margin % is 11.08%. Kim Forest Enterprise Co's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Kim Forest Enterprise Co (TPE:6645), the current FCF Margin % is 11.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kim Forest Enterprise Co (TPE:6645) Overvalued in 2026?
Based on GuruFocus' analysis, Kim Forest Enterprise Co stock appears to be undervalued.
The current stock price of NT$15.90 is trading 35.7% below its estimated GF Value™ of NT$24.71.
GuruFocus considers Kim Forest Enterprise Co to be Possible Value Trap.
Key valuation signals for TPE:6645:
FCF Margin %: 11.08%
GF Value™: NT$24.71 vs. price of NT$15.90 (35.7% below fair value)
No single metric tells the full story. See the TPE:6645 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kim Forest Enterprise Co Ltd is engaged in providing clinical medical information, genetic testing services, and biological information. It manufactures medical equipment and also produces drug products. The company's equipment includes Desktop microcentrifuge, Desktop large capacity centrifuge, Filter-type absorption spectrometer, Multifunctional spectrometer, and many more. Its reportable segments are Biomedical products which generates key revenue, and the Precision medicine segment. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the United States of America.
59GF Score
Get the complete analysis for TPE:6645
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6645 has been successfully added to your 
